Phase Ib study of Buparlisib plus Trastuzumab in patients with HER2-positive advanced or metastatic breast cancer that has progressed on Trastuzumab-based therapy
Buparlisib 联合曲妥珠单抗治疗 HER2 阳性晚期或转移性乳腺癌且在接受曲妥珠单抗治疗后出现进展的 Ib 期研究
期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-13-1070
Cristina Saura, Johanna Bendell, Guy Jerusalem, Shaun Su, Qinhua Ru, Stefan De Buck, David Mills, Sophie Ruquet, Ana Bosch, Ander Urruticoechea, Joseph T Beck, Emmanuelle Di Tomaso, David W Sternberg, Cristian Massacesi, Samit Hirawat, Luc Dirix, Jose Baselga